The goal of the colloquium is to showcase the synergistic interaction
between chemistry, biology, pharmacology, and bioinformatics in the process of drug development. Our aim is to promote the professional dialogue between students and experts from different disciplines interested in the processes of drug discovery and development. This conference provides a platform for undergraduate, graduate students, and post-doctoral fellows to present their research. This conference will also include a professional development session, and provides great networking opportunities.
Download DDDC – FINAL_PROGRAM
Call for Participation
The Conference Program Committee invites you to submit an abstract for either a poster or oral presentation. Abstracts are limited to 300 words in length.
For registration click here
Oral abstract deadline
May 26, 2017 June 1,2017
Poster abstract deadline
May 26, 2017, June 1,2017
Oral presentation acceptance June 5, 2017
Poster presentation acceptance June 5, 2017
We have sufficient space for all poster abstracts to be accepted.
Poster size limitation: 48″W x 36″H (122cm x 91cm)
For Venue and Hotel details, click here
Professor of Surgery and of Biochemistry and Molecular Biology
Indiana University School of Medicine
Title: “Evolving concepts of normal breast heterogeneity and its impact on tumor characterization and therapeutic targeting”
Center Director, National Center for Toxicological Research,
U.S. Food and Drug Administration, Jefferson, Arkansas
Professor, Pharmaceutical Sciences, University of Maryland Eastern Shore
Professor, College of Pharmacy, University of Kentucky